Akebia Therapeutics to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on kidney disease treatments, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 3, 2020. The company’s President, John P. Butler, and CFO, David A. Spellman, will engage in virtual meetings. A recording of their presentation will be accessible on the conference site and Akebia's investor page from November 24 to December 3, 2020. Akebia, founded in 2007 and based in Cambridge, Massachusetts, aims to enhance the quality of life for those affected by kidney disease.

CAMBRIDGE, Mass., Nov. 24, 2020 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will participate in the Piper Sandler 32^nd Annual Virtual Healthcare Conference.

John P. Butler, President and Chief Executive Officer, and David A. Spellman, Senior Vice President and Chief Financial Officer, will participate in virtual one-on-one meetings on Thursday, December 3, 2020.

A recording of Akebia's conference presentation is available via the Piper Sandler conference site as well as on the Investors section of the Company's website at https://ir.akebia.com, from November 24 to December 3, 2020. 

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-participate-in-piper-sandler-32nd-annual-virtual-healthcare-conference-301179379.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics participate in the Piper Sandler conference?

Akebia Therapeutics will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 3, 2020.

Who from Akebia will be attending the virtual conference?

John P. Butler, President and CEO, and David A. Spellman, Senior VP and CFO, will represent Akebia at the conference.

Where can I find Akebia's conference presentation recording?

The recording of Akebia's presentation will be available on the Piper Sandler conference site and Akebia's investor page from November 24 to December 3, 2020.

What is the main focus of Akebia Therapeutics?

Akebia Therapeutics is focused on developing and commercializing therapeutics for individuals affected by kidney disease.

Where is Akebia Therapeutics headquartered?

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.